독성학 약물 스크리닝 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 시험 유형별, 제품별, 용도별, 지역별, 경쟁별 세분화(2020-2030년)

The Global Toxicology Drug Screening Market will grow from USD 12.16 Billion in 2024 to USD 19.84 Billion by 2030 at a 8.50% CAGR. Toxicology drug screening involves the systematic evaluation of potential adverse effects of novel pharmaceutical compounds on biological systems during the initial stages of drug discovery and development. This market's expansion is fundamentally propelled by escalating global pharmaceutical research and development expenditures, which necessitate rigorous safety assessments before advancing to clinical trials.

Key Market Drivers

The expansion of the global toxicology drug screening market is significantly influenced by increasing pharmaceutical research and development investments. As pharmaceutical companies commit substantial capital to the discovery and development of novel drug candidates, the imperative for comprehensive and early-stage toxicity assessment grows. This commitment is exemplified by major industry players.

Key Market Challenges

A key challenging factor impacting the global toxicology drug screening market is the considerable complexity and inherent costs associated with developing and validating *in vitro* models that accurately forecast *in vivo* human toxicity. This directly hampers market expansion by creating significant barriers to the widespread adoption of advanced screening technologies. Pharmaceutical companies face substantial financial outlays in both the initial development and the subsequent rigorous validation required to ensure these *in vitro* models reliably predict human physiological responses.

Key Market Trends

The global toxicology drug screening market is significantly shaped by advancements in complex in vitro models, such as organ-on-a-chip and 3D cell culture technologies. These models offer enhanced physiological relevance compared to traditional 2D cell cultures, providing a more accurate representation of human biology and drug responses. Their adoption helps to reduce reliance on animal testing and can improve the predictive accuracy of preclinical toxicity assessments.

Key Market Players

• Bio-Rad Laboratories, Inc.
• Agilent Technologies, Inc.
• Merck KGaA
• Charles River Laboratories International, Inc.
• Enzo Life Sciences Inc.
• Eurofins Scientific SE
• Danaher Corporation
• Laboratory Corporation of America Holdings
• Promega Corporation
• The Jackson Laboratory

Report Scope:

In this report, the Global Toxicology Drug Screening Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Toxicology Drug Screening Market, By Testing Type:

• In Vitro
• In Vivo
• In Silico

Toxicology Drug Screening Market, By Product:

• Instruments
• Reagents and Consumables
• Animal Models
• Software
• Other Products

Toxicology Drug Screening Market, By Application:

• Immunotoxicity
• Systemic toxicity
• Developmental and Reproductive Toxicity (DART)
• Endocrine Disruption
• Other

Toxicology Drug Screening Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Toxicology Drug Screening Market.

Available Customizations:

Global Toxicology Drug Screening Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Toxicology Drug Screening Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Testing Type (In Vitro, In Vivo, In Silico)
  • 5.2.2. By Product (Instruments, Reagents and Consumables, Animal Models, Software, Other Products)
  • 5.2.3. By Application (Immunotoxicity, Systemic toxicity, Developmental and Reproductive Toxicity (DART), Endocrine Disruption, Other)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Toxicology Drug Screening Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Testing Type
  • 6.2.2. By Product
  • 6.2.3. By Application
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Toxicology Drug Screening Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Testing Type
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By Application
  • 6.3.2. Canada Toxicology Drug Screening Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Testing Type
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By Application
  • 6.3.3. Mexico Toxicology Drug Screening Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Testing Type
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By Application

7. Europe Toxicology Drug Screening Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Testing Type
  • 7.2.2. By Product
  • 7.2.3. By Application
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Toxicology Drug Screening Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Testing Type
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By Application
  • 7.3.2. France Toxicology Drug Screening Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Testing Type
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By Application
  • 7.3.3. United Kingdom Toxicology Drug Screening Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Testing Type
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By Application
  • 7.3.4. Italy Toxicology Drug Screening Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Testing Type
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By Application
  • 7.3.5. Spain Toxicology Drug Screening Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Testing Type
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By Application

8. Asia Pacific Toxicology Drug Screening Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Testing Type
  • 8.2.2. By Product
  • 8.2.3. By Application
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Toxicology Drug Screening Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Testing Type
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By Application
  • 8.3.2. India Toxicology Drug Screening Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Testing Type
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By Application
  • 8.3.3. Japan Toxicology Drug Screening Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Testing Type
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By Application
  • 8.3.4. South Korea Toxicology Drug Screening Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Testing Type
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By Application
  • 8.3.5. Australia Toxicology Drug Screening Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Testing Type
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By Application

9. Middle East & Africa Toxicology Drug Screening Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Testing Type
  • 9.2.2. By Product
  • 9.2.3. By Application
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Toxicology Drug Screening Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Testing Type
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By Application
  • 9.3.2. UAE Toxicology Drug Screening Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Testing Type
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By Application
  • 9.3.3. South Africa Toxicology Drug Screening Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Testing Type
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By Application

10. South America Toxicology Drug Screening Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Testing Type
  • 10.2.2. By Product
  • 10.2.3. By Application
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Toxicology Drug Screening Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Testing Type
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By Application
  • 10.3.2. Colombia Toxicology Drug Screening Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Testing Type
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By Application
  • 10.3.3. Argentina Toxicology Drug Screening Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Testing Type
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Toxicology Drug Screening Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Bio-Rad Laboratories, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Agilent Technologies, Inc.
• 15.3. Merck KGaA
• 15.4. Charles River Laboratories International, Inc.
• 15.5. Enzo Life Sciences Inc.
• 15.6. Eurofins Scientific SE
• 15.7. Danaher Corporation
• 15.8. Laboratory Corporation of America Holdings
• 15.9. Promega Corporation
• 15.10. The Jackson Laboratory

16. Strategic Recommendations

17. About Us & Disclaimer